NM_001130823.3:c.*211G>C

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_001130823.3(DNMT1):​c.*211G>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000726 in 606,160 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.000053 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000079 ( 0 hom. )

Consequence

DNMT1
NM_001130823.3 3_prime_UTR

Scores

2

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 0.354

Publications

0 publications found
Variant links:
Genes affected
DNMT1 (HGNC:2976): (DNA methyltransferase 1) This gene encodes an enzyme that transfers methyl groups to cytosine nucleotides of genomic DNA. This protein is the major enzyme responsible for maintaining methylation patterns following DNA replication and shows a preference for hemi-methylated DNA. Methylation of DNA is an important component of mammalian epigenetic gene regulation. Aberrant methylation patterns are found in human tumors and associated with developmental abnormalities. Variation in this gene has been associated with cerebellar ataxia, deafness, and narcolepsy, and neuropathy, hereditary sensory, type IE. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]
DNMT1 Gene-Disease associations (from GenCC):
  • autosomal dominant cerebellar ataxia, deafness and narcolepsy
    Inheritance: Unknown, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Genomics England PanelApp, Orphanet, Labcorp Genetics (formerly Invitae)
  • hereditary sensory neuropathy-deafness-dementia syndrome
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.58).
BS2
High AC in GnomAd4 at 8 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001130823.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DNMT1
NM_001130823.3
MANE Select
c.*211G>C
3_prime_UTR
Exon 41 of 41NP_001124295.1P26358-2
DNMT1
NM_001318730.2
c.*211G>C
3_prime_UTR
Exon 40 of 40NP_001305659.1
DNMT1
NM_001379.4
c.*211G>C
3_prime_UTR
Exon 40 of 40NP_001370.1P26358-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DNMT1
ENST00000359526.9
TSL:1 MANE Select
c.*211G>C
3_prime_UTR
Exon 41 of 41ENSP00000352516.3P26358-2
DNMT1
ENST00000340748.8
TSL:1
c.*211G>C
3_prime_UTR
Exon 40 of 40ENSP00000345739.3P26358-1
DNMT1
ENST00000592705.5
TSL:1
n.*4800G>C
non_coding_transcript_exon
Exon 41 of 41ENSP00000466657.1K7EMU8

Frequencies

GnomAD3 genomes
AF:
0.0000526
AC:
8
AN:
152212
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000103
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.0000793
AC:
36
AN:
453948
Hom.:
0
Cov.:
5
AF XY:
0.0000630
AC XY:
15
AN XY:
238214
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
12520
American (AMR)
AF:
0.00
AC:
0
AN:
18470
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
13662
East Asian (EAS)
AF:
0.00
AC:
0
AN:
31046
South Asian (SAS)
AF:
0.00
AC:
0
AN:
42868
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
32280
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
1980
European-Non Finnish (NFE)
AF:
0.000127
AC:
35
AN:
275126
Other (OTH)
AF:
0.0000385
AC:
1
AN:
25996
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.464
Heterozygous variant carriers
0
3
5
8
10
13
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000526
AC:
8
AN:
152212
Hom.:
0
Cov.:
32
AF XY:
0.0000403
AC XY:
3
AN XY:
74360
show subpopulations
African (AFR)
AF:
0.0000241
AC:
1
AN:
41460
American (AMR)
AF:
0.00
AC:
0
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5200
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4834
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10614
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000103
AC:
7
AN:
68046
Other (OTH)
AF:
0.00
AC:
0
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.000139
Hom.:
0
Bravo
AF:
0.0000680

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
Hereditary sensory neuropathy-deafness-dementia syndrome (1)
-
1
-
Hereditary sensory neuropathy-deafness-dementia syndrome;C3807295:Autosomal dominant cerebellar ataxia, deafness and narcolepsy (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.58
CADD
Benign
12
DANN
Benign
0.75
PhyloP100
0.35
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs772999851; hg19: chr19-10244132; API